Driving Business Value in Biosimilars Supply Chain Operations

Expanding the Use of BIOVIA Discoverant into New Application Areas

A global producer of biotherapeutics wanted to extend Discoverant’s value supporting a multi-year Advanced Process Control strategy. But the manufacturing of biosimilars involves a faster transition between clinical testing and large-scale manufacturing which introduces higher cost and increased effort during this phase. By leveraging low-cost, rapid hierarchy roll-outs the customer has been able to accelerate their biosimilars manufacturing process.